Sign In
Buy MGNX
$4.69
+0.110 (+2.40%)
At Close: Jun 23, 2026
SVB Leerink Maintains Outperform on Macrogenics, Raises Price Target to $27
05:08pm, Friday, 29'th May 2020Here's Why MacroGenics Is Tumbling 17.3% Today
04:45pm, Friday, 29'th May 2020
MacroGenics (NASDAQ: MGNX) shares are falling 17.3% as of 12:15 p.m. EST on Friday. The drop coincides with the release of the company's presentations at the annual American Society of Clinical Onc
U.S. Stocks Extend Losses Midday - Schaeffer's Investment Research
04:03pm, Friday, 29'th May 2020
All three indexes remain in the red for the day, but are clinging to weekly gains
MRSN, PAAS, WORK, ZYXI — Stock Charts To Watch
12:00am, Friday, 29'th May 2020
Stocks Analysis by Harry Boxer covering: Bed Bath & Beyond Inc, Ballard Power Systems Inc, Allegheny Technologies Incorporated, Apache Corporation. Read Harry Boxer's latest article on Investing.com
MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive Metastatic Breast Cancer
11:30am, Thursday, 28'th May 2020
MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based
BTIG Maintains Buy on Macrogenics, Raises Price Target to $35
12:00am, Thursday, 28'th May 2020MacroGenics Announces Registration Study of Flotetuzumab in Patients with Refractory Acute Myeloid Leukemia
11:30am, Wednesday, 27'th May 2020
MacroGenics, Inc. (MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announce
Edited Transcript of MGNX earnings conference call or presentation 5-May-20 8:30pm GMT
07:50am, Wednesday, 27'th May 2020
Q1 2020 MacroGenics Inc Earnings Call
MacroGenics Announces Registration Study Of Flotetuzumab In Patients With Refractory Acute Myeloid Leukemia
12:00am, Wednesday, 27'th May 2020The Week Ahead In Biotech: ASCO Presentations In The Spotlight
12:00am, Sunday, 24'th May 2020
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Surface Oncology Inc (...
Opaleye Management Inc. Buys Protara Therapeutics Inc, Eton Pharmaceuticals Inc, Kala ...
12:00am, Friday, 22'nd May 2020MacroGenics to Host Conference Call and Webcast to Review Preliminary Clinical Results for MGD013 and MGC018 to be Presented at ASCO
08:05pm, Thursday, 21'st May 2020
MacroGenics, Inc. (MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announce
